Hudson Executive Capital LP - Q4 2020 holdings

$1.38 Billion is the total value of Hudson Executive Capital LP's 7 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 28.6% .

 Value Shares↓ Weighting
DB BuyDEUTSCHE BANK A Gnamen akt$726,918,000
+33.0%
66,488,476
+2.5%
52.60%
-5.8%
CATM  CARDTRONICS PLC$305,164,000
+78.3%
8,644,8800.0%22.08%
+26.3%
USAT  USA TECHNOLOGIES INC$115,498,000
+19.8%
11,020,7650.0%8.36%
-15.2%
TVTY  TIVITY HEALTH INC$93,940,000
+39.7%
4,795,3100.0%6.80%
-1.0%
EHTH NewEHEALTH INC$52,993,000750,501
+100.0%
3.84%
VRAY  VIEWRAY INC$49,754,000
+9.1%
13,024,6840.0%3.60%
-22.7%
NTRA  NATERA INC$37,677,000
+37.8%
378,5890.0%2.73%
-2.4%
STOR ExitSTORE CAP CORP$0-890,800
-100.0%
-2.50%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-02-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
DEUTSCHE BANK AG21Q3 202388.0%
EAGLE PHARMACEUTICALS INC16Q4 201934.5%
NATERA INC15Q4 20224.6%
CARDTRONICS PLC14Q1 202143.3%
VIEWRAY INC14Q2 20238.2%
ATRICURE INC13Q3 201920.9%
CIT GROUP INC11Q2 201826.4%
TIVITY HEALTH INC11Q1 202212.3%
CORINDUS VASCULAR ROBOTICS I11Q3 20199.7%
CANTALOUPE INC10Q3 202311.8%

View Hudson Executive Capital LP's complete holdings history.

Latest significant ownerships (13-D/G)
Hudson Executive Capital LP Q4 2020 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
ViewRay, Inc.July 21, 20236,752,0933.7%
Akoya Biosciences, Inc.February 07, 20231,892,2045.0%
Liberated Syndication Inc.March 23, 20222,400,0008.6%
eHealth, Inc.March 11, 2022750,5012.8%
Talkspace, Inc.November 17, 202117,980,60011.2%
USA TECHNOLOGIES INCFebruary 26, 202111,995,76516.9%
Cardtronics plcDecember 15, 20208,644,88019.4%
TIVITY HEALTH, INC.May 11, 20204,795,3109.9%
EAGLE PHARMACEUTICALS, INC.January 16, 2020361,8972.6%
Corindus Vascular Robotics, Inc.Sold outOctober 31, 201900.0%

View Hudson Executive Capital LP's complete significant-ownership history.

Latest filings
TypeFiled
1442024-02-21
42024-02-21
SC 13D/A2024-02-21
13F-HR2024-02-14
13F-HR2023-11-14
13F-HR2023-08-14
SC 13D/A2023-07-21
13F-HR2023-05-15
13F-HR2023-02-14
SC 13D/A2023-02-07

View Hudson Executive Capital LP's complete filings history.

Compare quarters

Export Hudson Executive Capital LP's holdings